Page last updated: 2024-08-23

paroxetine and sulpiride

paroxetine has been researched along with sulpiride in 23 studies

Research

Studies (23)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's4 (17.39)18.2507
2000's13 (56.52)29.6817
2010's6 (26.09)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Topliss, JG; Yoshida, F1
Bleich, S; Gulbins, E; Kornhuber, J; Reichel, M; Terfloth, L; Tripal, P; Wiltfang, J1
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC1
Boriss, H; Braggio, S; Corbioli, S; Fontana, S; Helmdach, L; Longhi, R; Schiller, J; Vinco, F1
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY1
Bach, FW; Ekman, R; Langemark, M; Olesen, J; Rehfeld, JF; Schifter, S1
Langemark, M; Olesen, J1
Campbell, AD; Erwin, VG; Jones, BC; Womer, DE1
Fujiseki, Y; Inagaki, C; Kinoshita, T; Okugawa, G; Omori, K; Suzukawa, J1
Cassano, GB; Jori, MC1
Bogetto, F; Gandolfo, S; Maina, G; Vitalucci, A1
Bogetto, F; Marchiaro, L; Rasetti, R; Rivoira, E; Rocca, P1
Arai, H; Kumagai, R; Nagata, T; Ohnuma, T1
Argyropoulos, S; Hale, AS; Willner, P1
Kashima, H; Nomura, K; Suzuki, T; Takeuchi, H; Uchida, H; Watanabe, K1
Magalhães, PV1
Ikenouchi-Sugita, A; Nakamura, J; Yoshimura, R1
Kashima, H; Suzuki, T; Uchida, H; Watanabe, K1
Audi, EA; Biesdorf de Almeida, C; de Mello, JC; Klein, T; Roncon, CM1
Abaitua, I; Alonso-Ferreira, V; Hens, MJ; Posada de la Paz, M; Villaverde-Hueso, A1

Reviews

1 review(s) available for paroxetine and sulpiride

ArticleYear
[Review of pharmacological efficacies and side effects of antidepressants].
    Nihon rinsho. Japanese journal of clinical medicine, 2007, Volume: 65, Issue:9

    Topics: Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Fluvoxamine; Humans; Imipramine; Maprotiline; Paroxetine; Sulpiride; Trazodone

2007

Trials

8 trial(s) available for paroxetine and sulpiride

ArticleYear
Effect of sulpiride or paroxetine on cerebrospinal fluid neuropeptide concentrations in patients with chronic tension-type headache.
    Neuropeptides, 1994, Volume: 27, Issue:2

    Topics: Adult; Aged; Basal Metabolism; Calcitonin Gene-Related Peptide; Cholecystokinin; Chronic Disease; Dopamine D2 Receptor Antagonists; Dynorphins; Female; Humans; Male; Middle Aged; Neuropeptides; Paroxetine; Somatostatin; Sulpiride; Tension-Type Headache

1994
Sulpiride and paroxetine in the treatment of chronic tension-type headache. An explanatory double-blind trial.
    Headache, 1994, Volume: 34, Issue:1

    Topics: Adult; Aged; Chronic Disease; Double-Blind Method; Female; Headache; Humans; Male; Middle Aged; Muscle Contraction; Paroxetine; Pilot Projects; Sulpiride

1994
Efficacy and safety of amisulpride 50 mg versus paroxetine 20 mg in major depression: a randomized, double-blind, parallel group study.
    International clinical psychopharmacology, 2002, Volume: 17, Issue:1

    Topics: Adolescent; Adult; Aged; Amisulpride; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Middle Aged; Outpatients; Paroxetine; Psychiatric Status Rating Scales; Sulpiride

2002
Comparative efficacy of SSRIs and amisulpride in burning mouth syndrome: a single-blind study.
    The Journal of clinical psychiatry, 2002, Volume: 63, Issue:1

    Topics: Amisulpride; Antipsychotic Agents; Burning Mouth Syndrome; Humans; Male; Middle Aged; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Single-Blind Method; Sulpiride; Treatment Outcome

2002
A comparison of paroxetine versus paroxetine plus amisulpride in the treatment of dysthymic disorder: efficacy and psychosocial outcomes.
    Psychiatry research, 2002, Oct-10, Volume: 112, Issue:2

    Topics: Adult; Amisulpride; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Drug Therapy, Combination; Dysthymic Disorder; Female; Follow-Up Studies; Humans; Male; Middle Aged; Paroxetine; Personality Inventory; Social Adjustment; Social Behavior; Sulpiride; Treatment Outcome

2002
Dopaminergic mechanism of antidepressant action in depressed patients.
    Journal of affective disorders, 2005, Volume: 86, Issue:1

    Topics: Adult; Affect; Case-Control Studies; Citalopram; Depressive Disorder, Major; Dopamine Antagonists; Female; Fluoxetine; Humans; Male; Middle Aged; Motor Activity; Paroxetine; Receptors, Dopamine D2; Receptors, Dopamine D3; Selective Serotonin Reuptake Inhibitors; Sulpiride; Treatment Outcome

2005
Combined treatment with sulpiride and paroxetine for accelerated response in patients with major depressive disorder.
    Journal of clinical psychopharmacology, 2005, Volume: 25, Issue:6

    Topics: Adult; Antidepressive Agents, Second-Generation; Depressive Disorder, Major; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Paroxetine; Psychological Tests; Sulpiride; Time Factors; Treatment Outcome

2005
Should adjunctive antipsychotic treatment be continued in remitted patients with depression?
    Psychiatry and clinical neurosciences, 2009, Volume: 63, Issue:1

    Topics: Adult; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Depressive Disorder, Major; Drug Therapy, Combination; Female; Humans; Long-Term Care; Male; Paroxetine; Psychiatric Status Rating Scales; Sulpiride

2009

Other Studies

14 other study(ies) available for paroxetine and sulpiride

ArticleYear
QSAR model for drug human oral bioavailability.
    Journal of medicinal chemistry, 2000, Jun-29, Volume: 43, Issue:13

    Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship

2000
Identification of new functional inhibitors of acid sphingomyelinase using a structure-property-activity relation model.
    Journal of medicinal chemistry, 2008, Jan-24, Volume: 51, Issue:2

    Topics: Algorithms; Animals; Cell Line; Cell Line, Tumor; Chemical Phenomena; Chemistry, Physical; Enzyme Inhibitors; Humans; Hydrogen-Ion Concentration; Molecular Conformation; Quantitative Structure-Activity Relationship; Rats; Sphingomyelin Phosphodiesterase

2008
Physicochemical determinants of human renal clearance.
    Journal of medicinal chemistry, 2009, Aug-13, Volume: 52, Issue:15

    Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight

2009
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate.
    Bioorganic & medicinal chemistry letters, 2010, Dec-15, Volume: 20, Issue:24

    Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility

2010
Brain tissue binding of drugs: evaluation and validation of solid supported porcine brain membrane vesicles (TRANSIL) as a novel high-throughput method.
    Drug metabolism and disposition: the biological fate of chemicals, 2011, Volume: 39, Issue:2

    Topics: Absorption; Albumins; Animals; Brain; Brain Chemistry; Cell Membrane; Chromatography, High Pressure Liquid; Drug Evaluation, Preclinical; In Vitro Techniques; Lipids; Male; Microdialysis; Pharmaceutical Preparations; Protein Binding; Rats; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Swine; Tissue Distribution

2011
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
    Chemical research in toxicology, 2012, Oct-15, Volume: 25, Issue:10

    Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding

2012
Pharmacogenetics of cocaine: II. Mesocorticolimbic and striatal dopamine and cocaine receptors in C57BL and DBA mice.
    Pharmacogenetics, 1993, Volume: 3, Issue:4

    Topics: Animals; Benzamides; Benzazepines; Binding Sites; Carrier Proteins; Cerebral Cortex; Cocaine; Corpus Striatum; Dopamine Plasma Membrane Transport Proteins; Limbic System; Male; Membrane Glycoproteins; Membrane Transport Proteins; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Nerve Tissue Proteins; Paroxetine; Pharmacogenetics; Pyrrolidines; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, Drug; Serotonin Plasma Membrane Transport Proteins; Species Specificity; Sulpiride

1993
Long-term treatment with antidepressants increases glucocorticoid receptor binding and gene expression in cultured rat hippocampal neurones.
    Journal of neuroendocrinology, 1999, Volume: 11, Issue:11

    Topics: Amitriptyline; Animals; Antidepressive Agents, Tricyclic; Cells, Cultured; Desipramine; Dexamethasone; Gene Expression Regulation; Haloperidol; Hippocampus; Ketanserin; Mianserin; Neurons; Paroxetine; Phentolamine; Propranolol; Radioligand Assay; Rats; Receptors, Glucocorticoid; Receptors, Mineralocorticoid; RNA, Messenger; Sulpiride; Transcription, Genetic; Tritium

1999
Drug-related hyperprolactinemia.
    Prescrire international, 2003, Volume: 12, Issue:63

    Topics: Antidepressive Agents; Antipsychotic Agents; Female; Flunarizine; Fluoxetine; Fluvoxamine; Humans; Hyperprolactinemia; Indoramin; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sulpiride

2003
Visual and auditory hallucinations with excessive intake of paroxetine.
    Psychiatry and clinical neurosciences, 2003, Volume: 57, Issue:5

    Topics: Adult; Amisulpride; Antipsychotic Agents; Auditory Perception; Brain; Female; Hallucinations; Humans; Japan; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sulpiride; Visual Perception

2003
Open trials in psychiatry: comments on article by Uchida et Al.
    Journal of clinical psychopharmacology, 2007, Volume: 27, Issue:3

    Topics: Antidepressive Agents; Depressive Disorder, Major; Drug Therapy, Combination; Humans; Paroxetine; Sulpiride

2007
Anxiolytic effects of a semipurified constituent of guaraná seeds on rats in the elevated T-maze test.
    Planta medica, 2011, Volume: 77, Issue:3

    Topics: Animals; Anti-Anxiety Agents; Anxiety; Behavior, Animal; Disease Models, Animal; Dopamine Agents; Escape Reaction; Locomotion; Male; Maze Learning; Metergoline; Panic; Paroxetine; Paullinia; Phytotherapy; Plant Extracts; Rats; Rats, Wistar; Seeds; Serotonin Agents; Sulpiride

2011
Cost-effectiveness analysis of burning mouth syndrome therapy.
    Community dentistry and oral epidemiology, 2012, Volume: 40, Issue:2

    Topics: Amisulpride; Antidepressive Agents; Burning Mouth Syndrome; Clonazepam; Cost-Benefit Analysis; Decision Trees; Dental Care; Drug Costs; Health Care Costs; Humans; Paroxetine; Sertraline; Sulpiride

2012